Concepedia

Yuanrong Dai

YD

Statistics

Publications

27

Citations

843

H-Index

17

Active since

2011

Affiliations

Wenzhou Medical University(Current)

First Affiliated Hospital of Wenzhou Medical University

Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University

Fudan University

Central South University

Yuanrong Dai is an author at Wenzhou Medical University specializing in pharmacology, inflammation, and anti-inflammatory pharmacology.

ORCID

Publications per year

2011–2023

27

Publications

27

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury

Yali Zhang, Dandan Liang, Lili Dong et al. · Respiratory Research · 2015 · 92 citations · Full text

, , +17

Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2

Yi Wang, Xiaoou Shan, Yuanrong Dai et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 76 citations

, , +17

Shikonin inhibits myeloid differentiation protein 2 to prevent LPS‐induced acute lung injury

Yali Zhang, Tingting Xu, Zheer Pan et al. · British Journal of Pharmacology · 2017 · 71 citations · Full text

, , +17

Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury

Yali Zhang, Jianzhang Wu, Shilong Ying et al. · Scientific Reports · 2016 · 61 citations · Full text

, , +14

A Phase 1b Study of Ivonescimab, a Programmed Cell Death Protein-1 and Vascular Endothelial Growth Factor Bispecific Antibody, as First- or Second-Line Therapy for Advanced or Metastatic Immunotherapy-Naive NSCLC

Lei Wang, Yongzhong Luo, Shengxiang Ren et al. · Journal of Thoracic Oncology · 2023 · 58 citations · Full text

, , +17

1–5 of 27